0 false false false false false false false false false true false false false false false false No description of principal activity 2022-02-01 Sage Accounts Production Advanced 2021 - FRS102_2021 881 733 30 763 118 148 xbrli:pure xbrli:shares iso4217:GBP 08349465 2022-02-01 2023-01-31 08349465 2023-01-31 08349465 2022-01-31 08349465 2022-01-31 08349465 core:FurnitureFittings 2022-02-01 2023-01-31 08349465 bus:Director1 2022-02-01 2023-01-31 08349465 core:FurnitureFittings 2022-01-31 08349465 core:FurnitureFittings 2023-01-31 08349465 core:WithinOneYear 2023-01-31 08349465 core:WithinOneYear 2022-01-31 08349465 core:ShareCapital 2023-01-31 08349465 core:ShareCapital 2022-01-31 08349465 core:RetainedEarningsAccumulatedLosses 2023-01-31 08349465 core:RetainedEarningsAccumulatedLosses 2022-01-31 08349465 core:FurnitureFittings 2022-01-31 08349465 bus:Director1 2022-01-31 08349465 bus:Director1 2023-01-31 08349465 bus:Director1 2021-01-31 08349465 bus:Director1 2022-01-31 08349465 bus:Director1 2021-02-01 2022-01-31 08349465 bus:SmallEntities 2022-02-01 2023-01-31 08349465 bus:AuditExemptWithAccountantsReport 2022-02-01 2023-01-31 08349465 bus:FullAccounts 2022-02-01 2023-01-31 08349465 bus:SmallCompaniesRegimeForAccounts 2022-02-01 2023-01-31 08349465 bus:PrivateLimitedCompanyLtd 2022-02-01 2023-01-31
COMPANY REGISTRATION NUMBER: 08349465
Danamed Limited
Filleted Unaudited Financial Statements
31 January 2023
Danamed Limited
Statement of Financial Position
31 January 2023
2023
2022
Note
£
£
Fixed assets
Tangible assets
4
118
148
Current assets
Debtors
5
7,412
7,707
Cash at bank and in hand
93,895
109,228
------------
------------
101,307
116,935
Creditors: amounts falling due within one year
6
( 102,984)
( 104,897)
------------
------------
Net current (liabilities)/assets
( 1,677)
12,038
------------
------------
Total assets less current liabilities
( 1,559)
12,186
------------
------------
Net (liabilities)/assets
( 1,559)
12,186
------------
------------
Danamed Limited
Statement of Financial Position (continued)
31 January 2023
2023
2022
Note
£
£
Capital and reserves
Called up share capital
100
100
Profit and loss account
( 1,659)
12,086
------------
------------
Shareholders (deficit)/funds
( 1,559)
12,186
------------
------------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 January 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 19 May 2023 , and are signed on behalf of the board by:
Miss D Maciejewska
Director
Company registration number: 08349465
Danamed Limited
Notes to the Financial Statements
Year ended 31 January 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Unit 7 Jubilee Road, Workington, Cumbria, CA14 4HA, England.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered.
Taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Depreciation
-
20% reducing balance
4. Tangible assets
Fixtures and fittings
Total
£
£
Cost
At 1 February 2022 and 31 January 2023
881
881
------------
------------
Depreciation
At 1 February 2022
733
733
Charge for the year
30
30
------------
------------
At 31 January 2023
763
763
------------
------------
Carrying amount
At 31 January 2023
118
118
------------
------------
At 31 January 2022
148
148
------------
------------
5. Debtors
2023
2022
£
£
Other debtors
7,412
7,707
------------
------------
6. Creditors: amounts falling due within one year
2023
2022
£
£
Other creditors
102,984
104,897
------------
------------
7. Director's advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2023
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Miss D Maciejewska
( 104,087)
1,647
( 102,440)
------------
------------
------------
------------
2022
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Miss D Maciejewska
62,884
( 104,087)
( 62,884)
( 104,087)
------------
------------
------------
------------